These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17144232)

  • 1. Mitochondrial cytopathies, phenotypic heterogeneity and a high incidence.
    Ryan E; King MD; Rustin P; Mayne PD; Brown GK; Monavari AA; Walsh R; Treacy EP
    Ir Med J; 2006 Oct; 99(9):262-4. PubMed ID: 17144232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of pediatric mitochondrial respiratory chain disorders in northwest Spain.
    Castro-Gago M; Blanco-Barca MO; Campos-González Y; Arenas-Barbero J; Pintos-Martínez E; Eirís-Puñal J
    Pediatr Neurol; 2006 Mar; 34(3):204-11. PubMed ID: 16504790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal.
    Diogo L; Grazina M; Garcia P; Rebelo O; Veiga MA; Cuevas J; Vilarinho L; de Almeida IT; Oliveira CR
    Pediatr Neurol; 2009 May; 40(5):351-6. PubMed ID: 19380071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otolaryngologic manifestations of mitochondrial cytopathies.
    Jeyakumar A; Williamson ME; Brickman TM; Krakovitz P; Parikh S
    Am J Otolaryngol; 2009; 30(3):162-5. PubMed ID: 19410120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial diseases: a nosological update.
    Filosto M; Mancuso M
    Acta Neurol Scand; 2007 Apr; 115(4):211-21. PubMed ID: 17376118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical variability and diagnosis steps in childhood mitochondrial disease].
    Mercier S; Josselin de Wasch M; Labarthe F; Jardel C; Lombès A; Munnich A; Toutain A; Nivet H; Saliba E; Chantepie A; Castelnau P
    Arch Pediatr; 2009 Apr; 16(4):322-30. PubMed ID: 19233626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder.
    Koene S; Kozicz TL; Rodenburg RJ; Verhaak CM; de Vries MC; Wortmann S; van de Heuvel L; Smeitink JA; Morava E
    J Affect Disord; 2009 Apr; 114(1-3):327-32. PubMed ID: 18692904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
    Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
    Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA-related disorders.
    Mancuso M; Filosto M; Choub A; Tentorio M; Broglio L; Padovani A; Siciliano G
    Biosci Rep; 2007 Jun; 27(1-3):31-7. PubMed ID: 17484046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation.
    Finsterer J
    Acta Neurol Scand; 2007 Jul; 116(1):1-14. PubMed ID: 17587249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitochondrial disorders].
    Munnich A; de Lonlay P; Rötig A; Rustin P
    Bull Acad Natl Med; 2009 Jan; 193(1):19-41; discussion 41-3. PubMed ID: 19718979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses.
    Gibson K; Halliday JL; Kirby DM; Yaplito-Lee J; Thorburn DR; Boneh A
    Pediatrics; 2008 Nov; 122(5):1003-8. PubMed ID: 18977979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of mitochondrial disorders--past, present and future.
    Schaefer AM; Taylor RW; Turnbull DM; Chinnery PF
    Biochim Biophys Acta; 2004 Dec; 1659(2-3):115-20. PubMed ID: 15576042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA disease prevalence: still underrecognized?
    Manwaring N; Wang JJ; Mitchell P; Sue CM
    Ann Neurol; 2008 Oct; 64(4):471; author reply 471-2. PubMed ID: 18991348
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenotypic variations in 3 children with POLG1 mutations.
    Burusnukul P; de los Reyes EC
    J Child Neurol; 2009 Apr; 24(4):482-6. PubMed ID: 19189930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.
    Uusimaa J; Moilanen JS; Vainionpää L; Tapanainen P; Lindholm P; Nuutinen M; Löppönen T; Mäki-Torkko E; Rantala H; Majamaa K
    Ann Neurol; 2007 Sep; 62(3):278-87. PubMed ID: 17823937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychologic profile of a high-functioning family with a mitochondrial cytopathy.
    Neargarder SA; Carvalho JO; Sullivan KD
    Cogn Behav Neurol; 2007 Sep; 20(3):193-201. PubMed ID: 17846519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of autism spectrum disorder in Portugal: prevalence, clinical characterization, and medical conditions.
    Oliveira G; Ataíde A; Marques C; Miguel TS; Coutinho AM; Mota-Vieira L; Gonçalves E; Lopes NM; Rodrigues V; Carmona da Mota H; Vicente AM
    Dev Med Child Neurol; 2007 Oct; 49(10):726-33. PubMed ID: 17880640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic challenges of mitochondrial DNA disorders.
    Wong LJ
    Mitochondrion; 2007; 7(1-2):45-52. PubMed ID: 17276740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurological evolution of Pearson syndrome: case report and literature review.
    Lee HF; Lee HJ; Chi CS; Tsai CR; Chang TK; Wang CJ
    Eur J Paediatr Neurol; 2007 Jul; 11(4):208-14. PubMed ID: 17434771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.